IIHE

IIHEIIHEIIHE
  • Home
  • About Us
    • Our History
    • Our Work
  • Our Team
    • Board Members
    • President
    • Associates
    • Associate Scholars
    • Former Board Members
  • Global Work
    • Afghanistan
    • China
    • El Salvador
    • Iraq
    • Kazakhstan
    • Lebanon
    • Pakistan
    • Syria
    • Taiwan
    • Tajikistan
    • Turkey
    • US
    • Mental Health
  • News
    • Founders Resources
    • News on IIHE Founders
    • Policy
  • Contact Us
  • More
    • Home
    • About Us
      • Our History
      • Our Work
    • Our Team
      • Board Members
      • President
      • Associates
      • Associate Scholars
      • Former Board Members
    • Global Work
      • Afghanistan
      • China
      • El Salvador
      • Iraq
      • Kazakhstan
      • Lebanon
      • Pakistan
      • Syria
      • Taiwan
      • Tajikistan
      • Turkey
      • US
      • Mental Health
    • News
      • Founders Resources
      • News on IIHE Founders
      • Policy
    • Contact Us

IIHE

IIHEIIHEIIHE
  • Home
  • About Us
    • Our History
    • Our Work
  • Our Team
    • Board Members
    • President
    • Associates
    • Associate Scholars
    • Former Board Members
  • Global Work
    • Afghanistan
    • China
    • El Salvador
    • Iraq
    • Kazakhstan
    • Lebanon
    • Pakistan
    • Syria
    • Taiwan
    • Tajikistan
    • Turkey
    • US
    • Mental Health
  • News
    • Founders Resources
    • News on IIHE Founders
    • Policy
  • Contact Us

Kazakhstan

  • Activities have included collaborations with the Ministry of Health assessed the outcome of HIV and Tuberculosis treatment among co-infected patients. 
  • Studies have explored the association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients. 
  • As a resulting academic article observes: 
    • Drug-resistant tuberculosis (TB) poses a serious threat to public health in Kazakhstan. This paper presents findings related to TB treatment outcome and drug resistance status among people co-infected with human immunodeficiency virus (HIV) and TB in Kazakhstan.
    • A cohort study using data provided by the Kazakhstan Ministry of Health's National Tuberculosis Program for 2014 and 2015 was performed to understand factors associated with drug-resistant TB status and TB treatment outcome.
    • These results suggest that having drug-resistant TB is associated with a higher likelihood of completing treatment with successful outcome, even when controlling for receipt of ARV therapy.

Copyright © 2018 IIHEUS - All Rights Reserved.